The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)-4 Drug Master File in Japan (INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)-4 JDMF) empowers INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)-4 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)-4 JDMF during the approval evaluation for pharmaceutical products. At the time of INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)-4 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)-4 suppliers with JDMF on PharmaCompass.